Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability.


Por: Ballester P, Martinez, M, Inda MD, Javaloyes, A, Richdale, A, Muriel J, Belda, C, Toral, N, Morales, D, Fernandez, E and Peiro, A

Publicada: 1 nov 2019 Ahead of Print: 1 ago 2019
Resumen:
Intellectual disability (ID) and autism spectrum disorder (ASD) are common, co-occurring developmental disorders and are frequently associated with sleep problems. This study aimed to assess the effectiveness and tolerability of agomelatine as a pharmacotherapy for sleep problems in ASD adults with ID.

Filiaciones:
Ballester P:
 1 Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain

 2 Department of Clinical Pharmacology, Organic Chemistry and Paediatrics, Miguel Hernández University of Elche, Elche, Spain

Martinez, M:
 3 Chronobiology Lab, Department of Physiology, College of Biology, University of Murcia, Mare Nostrum Campus, Murcia Spain

 4 Ciber Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain

Inda MD:
 1 Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain

Javaloyes, A:
 5 Education Centre for Children and Adolescents with Autism, Mental Health Problems and Behavioural Disorders (EDUCATEA), Alicante, Spain

Richdale, A:
 6 Olga Tennison Autism Research Centre, School of Psychology and Public Health, La Trobe University, Melbourne, VIC, Australia

Muriel J:
 1 Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain

Belda, C:
 7 Infanta Leonor Autism Centre, Alicante, Spain

Toral, N:
 8 San Rafael Resources Centre, Santa Faz, Spain

Morales, D:
 9 Operations Research Centre, Miguel Hernández University of Elche, Elche, Spain

Fernandez, E:
 10 Bioengineering Institute, Miguel Hernández University of Elche, Elche, Spain

Peiro, A:
 1 Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain

 11 Clinical Pharmacology Department, Department of Health of Alicante, Alicante General Hospital, Alicante, Spain
ISSN: 02698811





JOURNAL OF PSYCHOPHARMACOLOGY
Editorial
SAGE Publications, 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 33 Número: 11
Páginas: 1395-1406
WOS Id: 000483621800001
ID de PubMed: 31423939

MÉTRICAS